Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
22.59
-0.50 (-2.17%)
Mar 31, 2025, 10:00 AM EDT - Market open
KNSA Employees
Kiniksa Pharmaceuticals International, had 315 employees as of December 31, 2024. The number of employees increased by 18 or 6.06% compared to the previous year.
Employees
315
Change (1Y)
18
Growth (1Y)
6.06%
Revenue / Employee
$1,343,616
Profits / Employee
-$137,121
Market Cap
1.64B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KNSA News
- 4 weeks ago - Big Pipeline Updates From Kiniksa Pharmaceuticals - Seeking Alpha
- 4 weeks ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 4 weeks ago - Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy - GlobeNewsWire
- 5 weeks ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire